Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-25 2:33 pm Sale | 2025-03-31 | 13G | CLOROX CO CLX | UBS Group AG | 0 0.000% | -10,084,448 (Position Closed) | Filing History |
| 2025-04-25 11:41 am Purchase | 2024-12-31 | 13G | CLOROX CO CLX | UBS Group AG | 10,084,448 8.200% | 10,084,448 (New Position) | Filing History |
| 2025-04-14 3:40 pm Sale | 2025-03-31 | 13G | UBS GROUP AG UBS | Norges Bank | 139,886,962 4.000% | -36,137,490 (-20.53%) | Filing History |
| 2025-02-10 10:59 am Purchase | 2024-12-31 | 13G | VIPSHOP HLDGS LTD SPONSORED AD VIPS | UBS Group AG | 15,943,270 18.300% | 14,338,948 (+893.77%) | Filing History |
| 2025-02-10 10:42 am Sale | 2024-12-31 | 13G | PIMCO ACCESS INCOME FD COM PAXS | UBS Group AG | 2,233,985 5.100% | -701,709 (-23.90%) | Filing History |
| 2025-02-10 09:26 am Purchase | 2024-12-31 | 13G | RENALYTIX PLC ADS RNLXY | UBS Group AG | 16,774,708 5.100% | 16,774,708 (New Position) | Filing History |
| 2025-02-10 09:13 am Sale | 2024-12-31 | 13G | LIBERTY BROADBAND CORP COM SER LBRDK | UBS Group AG | 0 0.000% | -7,781,165 (Position Closed) | Filing History |
| 2025-02-10 08:59 am Sale | 2024-12-31 | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | UBS Group AG | 0 0.000% | -21,491,881 (Position Closed) | Filing History |
| 2025-02-10 08:33 am Purchase | 2024-12-31 | 13G | COLOR STAR TECHNOLOGY CO LTD ADD | UBS Group AG | 1,486 7.100% | 1,486 (New Position) | Filing History |
| 2024-11-08 12:14 pm Purchase | 2024-09-30 | 13G | UBS GROUP AG UBS | Norges Bank | 176,024,452 5.080% | 176,024,452 (New Position) | Filing History |
| 2024-11-06 12:04 pm Purchase | 2024-09-30 | 13G | INFINERA CORPORATION INFN | UBS Group AG | 14,484,028 6.100% | 14,484,028 (New Position) | Filing History |
| 2024-11-04 10:49 am Purchase | 2024-09-30 | 13G | RAPID7 INC RPD | UBS Group AG | 3,941,537 6.300% | 3,941,537 (New Position) | Filing History |
| 2024-11-01 09:00 am Purchase | 2024-09-30 | 13G | ABRDN INCOME CREDIT STRATEGIES ACPPRA | UBS Group AG | 750,319 46.900% | 20,547 (+2.82%) | Filing History |
| 2024-10-31 10:43 am Purchase | 2024-09-30 | 13G | THORNBURG INCOME BLDR OPPORTUN TBLD | UBS Group AG | 1,803,654 5.600% | 1,803,654 (New Position) | Filing History |
| 2024-10-30 3:18 pm Sale | 2024-09-30 | 13G | COHEN & STEERS LTD DURATION LDP | UBS Group AG | 0 0.000% | -1,474,839 (Position Closed) | Filing History |
| 2024-10-30 11:30 am Purchase | 2024-09-30 | 13G | LIBERTY BROADBAND CORP COM SER LBRDK | UBS Group AG | 7,781,165 6.400% | 7,781,165 (New Position) | Filing History |
| 2024-10-30 11:04 am Purchase | 2024-09-30 | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | UBS Group AG | 21,491,881 6.900% | 21,491,881 (New Position) | Filing History |
| 2024-08-08 12:55 pm Sale | 2024-06-30 | 13G | SIGHT SCIENCES INC SGHT | UBS Group AG | 0 0.000% | -2,879,863 (Position Closed) | Filing History |
| 2024-08-08 12:48 pm Sale | 2024-06-30 | 13G | MARCUS CORP MCS | UBS Group AG | 0 0.000% | -1,299,728 (Position Closed) | Filing History |
| 2024-08-08 11:36 am Sale | 2024-06-30 | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | UBS Group AG | 0 0.000% | -2,114,700 (Position Closed) | Filing History |